Tech Company Financing Transactions
3Daughters Funding Round
3Daughters closed a $4.7 million Seed venture capital round on 7/11/2024. Investors included Argosy Foundation, Thairm Bio and private investors.
Transaction Overview
Company Name
Announced On
7/11/2024
Transaction Type
Venture Equity
Amount
$4,700,000
Round
Seed
Investors
Proceeds Purpose
Funds will support development of game-changing IUD (intrauterine device) for contraception through an IND filing in early 2025.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
241 Francis Avenue
Mansfield, MA 02048
USA
Mansfield, MA 02048
USA
Phone
Website
Email Address
Overview
3Daughters is a clinical development company focused on evolutionary, even revolutionary Healthcare for Women. We are starting by addressing a difficult, common but neglected problem, pain during IUD insertion. Intrauterine devices (IUDs) are one of the most effective forms of birth control, yet the 'fear' associated with insertion pain is the single greatest barrier for adoption.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mary Cicero
Chief Financial Officer
John Vacha
Chief Medical Officer
Gary Shangold
VP - Bus. Development
Shelley Amster
VP - Manufacturing
David Jacobs
Browse more venture capital transactions:
Prev: 7/11/2024: Vantem Global venture capital transaction
Next: 7/11/2024: Soda venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs